Our Response & Action to the CDC’s Ostomy Ads

Thanks to the many advocates voicing their opinions through social media, I decided to pick up the phone and call the American Cancer Society (ACS) and The Centers for Disease Control and Prevention (CDC) last week regarding the new round of ads that are a part of the “Tips From Former Smokers“ campaign. This public health…  Read More

Meet Lisa Fund Researcher: Dr. Noel FCC de Miranda

Fight Colorectal Cancer is thrilled to introduce the newest Lisa Fund award recipient, Dr. Noel FCC de Miranda. Dr. de Miranda has been awarded the 2015 Fight Colorectal Cancer-Michael’s Mission-AACR Fellowship to research early onset (under 50), late-stage colorectal cancer. This two-year grant will begin in July and will focus on increasing the ability of immune…  Read More

Immunotherapy & Colorectal Cancer – Part 2

Yesterday in Immunotherapy for Colorectal Cancer : Part 1 we covered the basics of immunotherapy and the definitions of active and passive treatments. Today we provide insights for current research & what’s on the horizon for immunotherapy for colon and rectal cancer patients. Here’s where we are Passive immunotherapy (defined in yesterday’s blog) has significantly impacted colorectal cancer treatment with targeted…  Read More

Immunotherapy and Colorectal Cancer – Part 1

In the last several months, there has been significant media coverage about the role of immunotherapy treatments for cancer.  The report on 60 Minutes in December noted there are the business and political aspects of immunotherapy development, which are common to most medical breakthroughs. The recent Cancer Film series on PBS, the Emperor of All Maladies, focused…  Read More

Young Adult Colorectal Cancer

Is colorectal cancer in adults under age 50 (often called early-onset colorectal cancer (CRC)) becoming more common among young people, and are they being diagnosed at later stages? YES and YES This week is the annual Young Adult Cancer Awareness Week and in light of this, we wanted to highlight the “Under 50″ patients who are impacted…  Read More

Evaluating 80% by 2018

At Call-on Congress we received several questions, one common one being, “How will we evaluate the success of the 80% by 2018 campaign?” The National Colorectal Cancer Roundtable (NCCRT) has chosen to use the “Behavioral Risk Factor Surveillance Survey” for overall evaluation of the 80% by 2018 initiative. While it’s true we won’t know the final results…  Read More